/PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Upstazaâ„¢ (eladocagene exuparvovec; PTC-AADC) received a positive opinion from the.
/PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and financial results for the first quarter ending March 31, 2022. "We.
/PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the following conferences: Bank of.
/PRNewswire/ PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the following conferences: Bank of.